Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
VYGR
#2924
Voyager Therapeutics, Inc. Common Stock
4.100
0
+0.12%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+0.12%
Monthly Change
+4.06%
6 month change
-11.83%
Year Change
-11.83%
Previous Close
4.095
0
Open
4.100
0
Bid
Ask
Low
4.100
0
High
4.100
0
Volume
37
Markets
US Stock Market
Healthcare
VYGR
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
54.63 M
55.21 M
55.34 M
55.47 M
55.6 M
—
Valuation ratios
Enterprise value
207.03 M
241.66 M
112.28 M
128.57 M
214.53 M
697.03 M
Price to earnings ratio
9.59
-5.02
-2.35
-1.69
-2.16
-11.22
Price to sales ratio
1.77
4.09
2.92
4.23
8.69
19.93
Price to cash flow ratio
-11.52
21.36
-33.08
3.07
2.34
-6.31
Price to book ratio
0.26
1.09
0.16
0.16
0.26
1.67
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.02
0.09
0.09
0.1
0.1
0.38
Return on equity %
0.03
0.12
0.11
0.14
0.13
0.49
Return on invested capital %
66.85
130.88
97.47
113.11
116.47
457.92
Gross margin %
100
100
100
100
100
400
Operating margin %
56.02
607.82
533.74
704.33
228.31
2 074.2
EBITDA margin %
—
—
—
—
—
—
Net margin %
36.76
547.33
477.25
641.96
208.15
1 874.68
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8.45
5.56
6.1
5.43
6.19
23.27
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.06
0.02
0.02
0.02
0.04
0.09
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.46
0.25
0.65
0.57
0.53
2
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
5.97
5.76
5.06
4.47
3.89
19.18
Net current asset value per share
6.46
4.8
4.2
3.88
3.73
16.62
Tangible book value per share
5.71
5.2
4.67
4.16
3.74
17.77
Working capital per share
5.69
3.94
3.51
3.17
3.13
13.75
Book value per share
5.71
5.2
4.67
4.16
3.74
17.77
News
Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Lag Estimates
Alzheimer's Clinical Trial Results, Sadly Running True To Form
J&J Halts Alzheimer's Trial After Drug Fails To Slow Clinical Decline - Johnson & Johnson (NYSE:JNJ)
Voyager Therapeutics 목표 주가, H.C. Wainwright, 25달러로 하향
Voyager Therapeutics stock price target lowered to $25 at H.C. Wainwright
Voyager Therapeutics, Stifel 컨퍼런스서 신경 치료 혁신 발표
Voyager Therapeutics at Stifel Conference: Neurotherapeutic Innovations
보이저 테라퓨틱스 목표 주가, Leerink Partners, 12달러로 상향
Voyager Therapeutics stock price target raised to $12 by Leerink Partners
Voyager Therapeutics Inc Q3 실적, 수익 예상치를 넘어
Voyager Therapeutics Inc earnings beat by $0.05, revenue topped estimates
Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates